Oncology & Cancer

Latest vaccine study supports immune targeting of brain tumors

An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly ...

Oncology & Cancer

Cancer-seeking 'smart bombs' target kidney cancer cells

Researchers are halting kidney cancer with a novel form of radioimmunotherapy that zeroes in on antigens associated with renal cell carcinoma. Patients with progressive kidney cancer receiving up to three doses of the therapy ...

page 12 from 12